Salt Lake City, UT, United States of America

Chadwick Thelen Davis

This inventor holds 1 USPTO granted patent. Top assignee: Recursion Pharmaceuticals, Inc.. Active years: 2026.


Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Chadwick Thelen Davis: Innovator in Cell-Based Screening Assays

Introduction

Chadwick Thelen Davis is a notable inventor based in Salt Lake City, UT (US). He has made significant contributions to the field of biotechnology, particularly in the design of cell-based screening assays. His innovative approach has the potential to enhance the efficiency and effectiveness of experimental designs in this area.

Latest Patents

Chadwick holds a patent for "Methods and user interfaces for designing cell-based screening assay experiments." This patent describes a method that involves receiving inputs through a graphical user interface to define various parameters for conducting cell-based screening assays. The method includes identifying template plate definitions, disease reagents, treatment reagents, and generating a design for the experiment based on these inputs. This invention is crucial for researchers looking to streamline their experimental processes.

Career Highlights

Chadwick is currently employed at Recursion Pharmaceuticals, Inc., where he applies his expertise in developing innovative solutions for drug discovery and development. His work focuses on leveraging technology to improve the design and execution of biological experiments. With a patent portfolio that includes 1 patent, he continues to contribute to advancements in the field.

Collaborations

Chadwick collaborates with talented individuals such as Adam Smith Murray and Anthus John Williams. These partnerships enhance the innovative environment at Recursion Pharmaceuticals, fostering creativity and the development of cutting-edge solutions.

Conclusion

Chadwick Thelen Davis is a prominent figure in the realm of biotechnology, with a focus on improving cell-based screening assays. His contributions through patents and collaborations reflect his commitment to advancing scientific research and innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…